Skip to main content

Pravin Anand and Neeti Wilson look at the workings of intellectual property rights in the life sciences industry.

An in-depth look into the interaction between intellectual property rights and the protection of small molecules , particularly in the pharmaceutical sector, second-generation inventions, DNA, and biological and personalised medicine. The chapter also looks at the intricacies of compulsory licensing, patent infringement and enforcement.

Protection of patent also requires ascertaining ownership and compensation, and the ancillary IP involved in protecting branding and designs.

This chapter was published in IP in the Life Sciences.

To continue reading, please contact us at email@anandandanand.com

Most Recent

News & Insights

VIEW ALL
News & Updates, Thought Leadership
May 19, 2026

First published by Asialaw. Authors: Prachi Agarwal and Medha Singh Introduction: Copyright law, particularly in the domain of literary works, grapples

Copyright in Literary Works: When themes converge but expressions diverge
News & Updates, Thought Leadership
May 08, 2026

First published by Asialaw. Authors: Safir Anand and Ritu Bhargava India’s online gaming sector has entered a decisive new phase. With the Government’s

A New Era for Digital Play: India’s Online Gaming Regulator Comes into Force
News & Updates, Thought Leadership
May 06, 2026

First published by Lexology. Authors: Safir Anand and Rashi Chandhoke In recent years, the intellectual property (IP) ecosystem has undergone a significant

India Waives IP Filing Fees for Sports Sector
Thought Leadership
Apr 30, 2026

First published by SpicyIP. By: Lakshmidevi Somanath India’s trademark register is quietly bleeding value. Each year, marks with real commercial recall

Dead Marks, Live Assets – The Case for a Registry Supervised Auction of Lapsed Trademarks in India